BNR:XETRA-Brenntag SE (EUR)

COMMON STOCK | Specialty Chemicals | XETRA

Last Closing Price

EUR 65.04

Change

+0.16 (+0.25)%

Market Cap

EUR 10.02B

Volume

0.31M

Average Target Price

EUR 61.00 (-6.21%)
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Brenntag SE purchases and supplies industrial and specialty chemicals, and ingredients in Europe, the Middle East, Africa, North America, Latin America, the Asia Pacific, and internationally. It provides value-added services, such as just-in-time delivery, product mixing, blending, repackaging, inventory management, and drum return handling, as well as technical and laboratory services for specialty chemicals. The company serves customers in various end-market industries, including adhesives, paints, oil and gas, food, water treatment, personal care, and pharmaceuticals. Brenntag SE was founded in 1874 and is based in Essen, Germany. Address: Messeallee 11, Essen, Germany, 45131

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-03-03 )

Largest Industry Peers for Specialty Chemicals

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
LIN:XETRA Linde plc

-3.70 (-1.76%)

EUR109.66B 44.58 14.23
SY1:XETRA Symrise AG

-2.36 (-2.37%)

EUR13.50B 42.97 21.12
EVK:XETRA Evonik Industries AG

+0.29 (+1.01%)

EUR13.44B 24.32 5.62
1COV:XETRA Covestro AG

-0.20 (-0.32%)

EUR12.08B 25.19 8.38
FPE3:XETRA Fuchs Petrolub SE

-0.24 (-0.52%)

EUR5.79B 28.23 15.09
FPE:XETRA Fuchs Petrolub SE

-0.10 (-0.27%)

EUR5.77B 22.50 15.09
LXS:XETRA LANXESS Aktiengesellschaft

+0.86 (+1.35%)

EUR5.48B 6.57 3.85
CE2:XETRA CropEnergies AG

-0.24 (-2.05%)

EUR1.02B 11.92 6.24
UZU:XETRA Uzin Utz AG

+2.00 (+2.90%)

EUR0.35B 16.87 7.58
ACT:XETRA AlzChem Group AG

+0.30 (+1.22%)

EUR0.25B 15.62 4.79

ETFs Containing BNR

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Specialty Chemicals)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.68% 58% F 43% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.68% 58% F 43% F
Trailing 12 Months  
Capital Gain 50.38% 91% A- 91% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 50.38% 91% A- 91% A-
Trailing 5 Years  
Capital Gain 40.02% 45% F 60% D-
Dividend Return 9.36% 56% F 35% F
Total Return 49.39% 45% F 64% D
Average Annual (5 Year Horizon)  
Capital Gain 2.79% 55% F 51% F
Dividend Return 1.89% 64% D 70% C-
Total Return 4.67% 64% D 58% F
Risk Return Profile  
Volatility (Standard Deviation) 16.48% 64% D 37% F
Risk Adjusted Return 28.35% 73% C 52% F
Market Capitalization 10.02B 67% D+ 85% B
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Specialty Chemicals)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 21.55 67% D+ 57% F
Price/Book Ratio 2.85 42% F 47% F
Price / Cash Flow Ratio 11.40 42% F 40% F
EV/EBITDA 9.36 50% F 64% D
Management Effectiveness  
Return on Equity 13.29% 67% D+ 71% C-
Return on Invested Capital 10.08% 67% D+ 71% C-
Return on Assets 5.05% 58% F 76% C
Debt to Equity Ratio 54.24% 50% F 49% F
Technical Ratios  
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 1.18 42% F 23% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector